Press Releases

Newsroom
In the News
Press Releases
Resources for Journalists

Press Releases

Share
Share
and/or
497 News Releases found
Memorial Sloan Kettering Cancer Center Announces Strategic Real Estate Investments

Memorial Sloan Kettering Cancer Center (MSK) today announced details of strategic real estate investments that will support the world class cancer center into the future. In March 2022, MSK announced plans to build a new, state-of-the-art cancer care Pavilion on the Upper East Side campus to address the evolving cancer care needs of patients over the next century.
MSK Awards & Appointments August 2022

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments for August 2022.
Michael J. Morris, MD; Katherine Panageas, DrPH; Deb Schrag, MD.; and Peter D. Stetson, MD
Memorial Sloan Kettering Cancer Center Receives National Cancer Institute Grant to Establish New Telehealth Research Center

Memorial Sloan Kettering Cancer Center (MSK) today announced it has received a new grant from the National Cancer institute (NCI), part of the National Institutes of Health, under the umbrella of the Cancer Moonshot, to create the MATCHES (Making Telehealth Delivery of Cancer Care at Home Effective and Safe) Telehealth Research Center at MSK, a first of its kind.
New York Proton Center Celebrates 3rd Anniversary

The New York Proton Center (NYPC) celebrated its third anniversary, after opening its doors for treatment in August 2019.
MSK Awards & Appointments July 2022

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments:
MSK's 1275 York Ave location
Memorial Sloan Kettering Cancer Center Ranked Among the Best Hospitals for Cancer Care by U.S. News & World Report for 33 Consecutive Years

Memorial Sloan Kettering Cancer Center (MSK) has been recognized as the number two hospital for cancer care in the nation by U.S. News & World Report in its annual Best Hospitals listing. Since these prestigious rankings were established more than 30 years ago, MSK has consistently ranked among the top two cancer hospitals in the country.
MSK Commack
A Gift in Memory of "Nonna": Memorial Sloan Kettering Cancer Center and the Nonna's Garden Foundation Celebrate Major Gift on Long Island

Memorial Sloan Kettering established The Nonna's Garden Foundation Initiative for Cancer Care and Research and recently renamed its first freestanding regional location on Long Island, following a generous $50 million gift from Mike and Maria Repole and the Nonna's Garden Foundation.
Dr. Selwyn M. Vickers
Dr. Selwyn M. Vickers Named President and CEO of Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center (MSK) today announced that Selwyn M. Vickers, MD, FACS, an internationally recognized pancreatic cancer surgeon and researcher, a pioneer in cancer health disparities research, and an academic medical leader, has been selected to serve as its next President and Chief Executive Officer.
MSK Awards & Appointments June 2022

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.
Luis Alberto Diaz, Jr., MD and Andrea Cercek, MD
ASCO 2022: 100% Complete Response Rate in MMRd Locally Advanced Rectal Cancer Seen in Pivotal ‘Immunoablative’ Neoadjuvant Immunotherapy Clinical Trial

Breakthrough findings were presented at the 2022 ASCO Annual Meeting and published in The New England Journal of Medicine today by researchers at Memorial Sloan Kettering Cancer Center (MSK) confirming a clinical complete response in all 14 patients who received the immunotherapy treatment dostarlimab as a first-line treatment for mismatch repair-deficient (MMRd) locally advanced rectal cancer. This new approach of “immunoablative” therapy uses immunotherapy to replace surgery, chemotherapy and radiation to remove cancer.